| Application no. and date | 15721027.9 (espacenet) (Federated) (European Patent Register), 20150429 | | Patent/reg. no. and date | DK/EP 3137621, 20190717 | | Publication date | 20170308 | | Priority no. and date | GB 201407525, 20140429 | | EP pub. no. and date |
EP 3137621 20170308 | | Effective date | | | Applicant/owner | Ipsen Bioinnovation Limited, 102 Park Drive
Milton Park
Abingdon, Oxfordshire OX14 4RY, GB | | Applicant ref. no. | P81903744DK00E | | Inventor | PALAN, Shilpa, Ipsen Bioinnovation Limited
102 Park Drive
Milton Park
Abingdon
Oxfordshire OX14 4RY, GB,
LIU, Sai Man, Ipsen Bioinnovation Limited
102 Park Drive
Milton Park
Abingdon
Oxfordshire OX14 4RY, GB,
HACKETT, Gavin Stephen, Ipsen Bioinnovation Limited
102 Park Drive
Milton Park
Abingdon
Oxfordshire OX14 4RY, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , C12P 21/06 (2006.01) | | Title | Fremstilling af rekombinante clostridium botulinum-neurotoksiner | | Int. application no. | GB2015051250 | | Int. publication no. | WO2015166242 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
